* Disclaimer: All are subject to change
DAY 1: Conference (7th December 2022)
Time
Activities
0800
Registration
0830
Welcome & Opening Address
0845
Plenary Session 1
Cancer Immunotherapy in 2022 – End of the Beginning
Associate Professor Dr. Toh Han Chong
(National Cancer Centre, Singapore)
Chairperson: Associate Professor Dr. Rozita Abdul Malik (University of Malaya, Malaysia)
0930
Forum 1
Cancer Drug Access
Moderator: Associate Professor Dr. Bahariah Khalid
(Universiti Putra Malaysia)
Panelists:
– Professor Dr. How Soon Hin (International Islamic University Malaysia)
– Dr. Murallitharan Munisamy (National Cancer Society Malaysia)
– Dr. Yolanda Augustin (St George’s University of London, UK)
– Professor Datin Dr. Rozi Mahmud (Universiti Putra Malaysia)
– Professor Dato’ Dr. Fuad Ismail (Universiti Kebangsaan Malaysia)
– Dr. Azrul Mohd Khalib (Galen Centre for Health and Social Policy)
– Mr. Jegatheswaran Panderengen (Novartis Corporation, Malaysia)
1030
Morning Coffee/Tea Break
Poster Viewing & Judging Session 1
1100
Sponsor Talk 1
Mr. Jegatheswaran Panderengen
(Novartis Corporation, Malaysia)
1125
Invited Talk 1
ATLAS Project and the Future of International Collaborative Clinical Research in Asia
Dr. Mitsumi Terada
(National Cancer Center, Japan)
Chairperson: Dr. Yolanda Augustin (St George’s University of London, United Kingdom)
1145
Invited Talk 2
Developing Affordable Cancer Therapeutics in Low and Middle Income Countries
Dr. Yolanda Augustin
(St George’s University of London, United Kingdom)
Chairperson: Dr. Mastura Md Yusof (Pantai Hospital Kuala Lumpur, Malaysia)
1205
Invited Talk 3
Triple Negative Breast Cancer; Tumour Biology and Optimisation of Clinical Outcome
Dr. Mastura Md Yusof
(Pantai Hospital Kuala Lumpur, Malaysia)
Chairperson: Dr. Mitsumi Terada (National Cancer Center, Japan)
1225
Q&A Session 1
– Dr. Mitsumi Terada
– Dr. Yolanda Augustin
– Dr. Mastura Md Yusof
1240
Sponsored Lunch Talk (MyGenome Institute)
Networking
1340
Plenary Session 2
Targeting Treatment Resistance in Head and Neck Cancer through Unravelling Molecular Mechanisms
Professor Dr. Goh Boon Cher
(National University of Singapore, Singapore)
Chairperson: Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)
1425
Invited Talk 4
Updates on Treatment of Gastroesophageal Cancers
Professor Dr. Ho Gwo Fuang
(Universiti of Malaya, Malaysia)
Chairperson: Dr. Mastura Md Yusof (Pantai Hospital Kuala Lumpur, Malaysia)
1445
Invited Talk 5
Targeting Lipid Metabolism in Non-Small Cell Lung Cancer Therapy
Dr. Azhar Bin Ali
(National University of Singapore, Singapore)
Chairperson: Dr. Jonathan Lim Chee Woei (Universiti Putra Malaysia)
1505
Q&A Session 2
– Professor Dr. Ho Gwo Fuang
– Dr. Azhar Bin Ali
1515
Sponsor Talk 2
Johnson & Johnson Sdn Bhd, Malaysia
1540
Afternoon Coffee/Tea Break
Poster Viewing & Judging Session 2
1610
Parallel Oral Sessions 1
Cancer Drug Discovery
Translational Cancer Medicine
1710
Invited Talk 6
Insights into Advanced Non-Small Cell Lung Cancer Patients with MET Alterations
Emeritus Professor Dr. Liam Chong Kin
(Universiti of Malaya, Malaysia)
Chairperson: Professor Dr. How Soon Hin (International Islamic University Malaysia)
1730
Invited Talk 7 (virtual)
Exploiting New Cancer Drug Targets that Drive Drug Resistant and Metastatic Disease
Professor Dr. Andrew D Westwell
(Cardiff University, United Kingdom)
Chairperson: Professor Dr. Gopal Natesan (MAHSA University)
1750
Q&A Session 3
– Emeritus Prof Dr. Liam Chong Kin
– Professor Dr. Andrew D Westwell
1800
Networking
1900
Gala Dinner
DAY 2: Conference (8th December 2022)
Time
Activities
0900
Plenary Session 3
The Identification of a Group of Self-Assembling, Trimetallic Cryptands with Multi-Kinase Inhibitor Activity Using a Phenotypic Approach to Drug Discovery
Professor Dr. Roger Phillips
(University of Huddersfield, United Kingdom)
Chairperson: Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)
0945
Invited Talk 8
Emerging Immuno-cellular therapy in the Treatment of Diffuse large B-cell Lymphoma
Professor Dr. Bee Ping Chong
(Universiti of Malaya, Malaysia)
Chairperson: Associate Professor Dr. Bahariah Khalid (Universiti Putra Malaysia)
1005
Invited Talk 9
Cancer-Associated Fibroblasts as Potential Therapeutic Targets in Head and Neck Cancer
Professor Dr. Ian Paterson
(Universiti of Malaya, Malaysia)
Chairperson: Dr. Lee Sau Har (Taylor’s University)
1025
Q&A Session 4
– Professor Dr. Bee Ping Chong
– Professor Dr. Ian Paterson
1035
Morning Coffee/Tea Break
Poster Viewing & Judging Session 3
1105
Invited Talk 10
Development of Biomarkers in Clinical Trials
Dr. Magdalena B Wozniak
(Novartis Pharma Ltd, Ireland)
Chairperson: Dr. Foo Jhi Biau (Taylor’s University, Malaysia)
1125
Invited Talk 11
Immune-checkpoint-inhibitors for Biliary Tract Cancer in the Era of Precision Medicine
Associate Professor Dr. Wan Zamaniah Wan Ishak
(University of Malaya, Malaysia)
Chairperson: Professor Dr. Bee Ping Chong (University of Malaya, Malaysia)
1145
Q&A Session 5
– Dr. Magdalena B Wozniak
– Associate Professor Dr. Wan Zamaniah Wan Ishak
1155
Parallel Oral Sessions 2
Cancer Drug Discovery
Translational Cancer Medicine
1255
Lunch
Networking
1355
Invited Talk 12
Tips to Prepare a Successful Grant Proposal
Professor Dr. Roger Phillips
(University of Huddersfield, United Kingdom)
Chairperson: Associate Professor Dr. Steven Lim Siong Meng (Universiti Teknologi MARA (UiTM), Malaysia)
1425
Forum 2
Publishing in a High Impact Journal
Moderator: Dr. Chua Eng Wee (Universiti Kebangsaan Malaysia)
Panelists:
– Professor Dr. Johnson Stanslas (Universiti Putra Malaysia)
– Professor Dr. Ian Paterson (University of Malaya, Malaysia)
– Professor Dr. Goh Boon Cher (National University of Singapore, Singapore)
1515
Sponsor Talk 3
Accelerating Cancer Biology Research with Agilent’s Cell Biology Portfolio
Mr. David Chung Tze Yang
(Agilent Technologies (Malaysia) Sdn Bhd)
1540
Afternoon Coffee/Tea Break
Networking
1610
Plenary Session 4 (virtual)
Precision Medicine in Lymphoid Malignancies
Professor Dr. Richard Rosenquist Brandell
(Karolinski Institute, Sweden)
Chairperson: Dr. Chua Eng Wee (Universiti Kebangsaan Malaysia)
1655
Awards Presentation
Closing Remark
1730
Networking
* Disclaimer: All are subject to change